EX-31 6 ex31-2.htm

Exhibit 31.2

Section 302 CFO Certification

I, Lawrence M. Christian, certify that:

1.     I have reviewed this annual report on Form 10-K of Antares Pharma, Inc.;

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
        make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
        the period covered by this annual report; and

3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
         respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
         annual report.

4.      The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
        defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), for the registrant and have:

        a)         designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its
                    consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report
                     is being prepared;

        b)         evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions
                    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
                    on such evaluation; and

        c)         disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s
                    most recent fiscal year that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
                    over financial reporting; and

5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
        reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent
        functions):

        a)         all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
                    reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

        b)         any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s
                     internal control over financial reporting.

Date:    March 17, 2005

/s/ Lawrence M. Christian
————————————————
Lawrence M. Christian
Vice President – Finance, Secretary and Chief Financial Officer